Technical Anonymisation Group (TAG): First meeting

Date: 29/11/2017 to 30/11/2017
Location: European Medicines Agency, London, UK

During its first meeting the TAG discussed the revision of clinical reports published between October 2016 and October 2017 performed by EMA and by the pharmaceutical industry's users software exchange organisation (PhUSE). The group shared industry's and EMA's experience with the anonymisation and review of clinical reports, respectively, and discussed the following issues:

  • the impact of anonymisation on data utility;
  • legal issues related to the anonymisation of clinical reports, including the impact of the general data protection regulation;
  • quantitative methods to measure the risk of re-identification and adversary knowledge.

Documents

How useful was this page?

Add your rating
Average
3 ratings